An estimated 5,000 people in the United States are living with Eosinophilic Granulomatosis with Polyangiitis (EGPA), a rare ...

Nasal microbiota transplantation could revolutionise the treatment of chronic rhinosinusitis and respiratory tract infections. Learn more!

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...

FMGE 2025: The exam was held on January 12, 2025. The National Board of Examinations in Medical Sciences (NBEMS) has released the results for the Foreign Medical Graduates Examination (FMGE).

Ramadan 2025 coincides with the term-end exams for international curriculum schools and the third-term exams for Indian curriculum schools, which are traditionally scheduled between February and ...

On Sunday, applicants took exams in science and math, as well as informatics, a new subject involved in computational systems that was introduced following revisions to the country's school ...

The first day of the annual exams started on Saturday at 651 venues across the country. The revised test for university admissions was launched in 2021. This year's edition is employing a ...